Search results
Novavax (NVAX) Outpaces Stock Market Gains: What You Should Know
Zacks via Yahoo Finance· 1 year agoIn the latest trading session, Novavax (NVAX) closed at $12.41, marking a +1.22% move from the...
Novavax (NVAX) Q2 Earnings Beat, Stock Down 4% on '23 Sales Cut
Zacks via Yahoo Finance· 9 months agoNovavax (NVAX) reports better-than-expected Q2 earnings results, as earnings and revenues beat...
Novavax Stock Plummets As 'Market Dynamics' Crush Its 2022 Sales Outlook
Investor's Business Daily· 2 years agoNovavax slashed its 2022 outlook on tumbling demand for Covid vaccines, leading NVAX stock to crash...
Is It Too Late to Buy Novavax Stock?
Motley Fool· 2 years agoBiotech company Novavax (NASDAQ: NVAX) has had a terrible year on the stock market, with its shares down by 86% year to date. The company does still face...
Better Bull Market Buy: Novavax vs. Pfizer
Motley Fool via Yahoo Finance· 2 months agoIt's official: The S&P 500 is in a bull market after reaching a new all-time high last month. The index actually has been in this positive market phase...
Novavax (NVAX) Q1 Earnings Lag, Stock Up 28% on Upbeat '23 View
Zacks via Yahoo Finance· 12 months agoNovavax (NVAX) reports dismal Q1 earnings results, as earnings and revenues miss estimates. However,...
1 Reason to Buy Novavax Stock Hand Over Fist and 1 Reason to Sell
Motley Fool via Yahoo Finance· 3 months agoNovavax (NASDAQ: NVAX) shares have offered investors a roller coaster ride over the past few years....
Why Novavax Stock Is Tumbling Today
Motley Fool· 2 years agoWhat happened Shares of Novavax (NASDAQ: NVAX) were tumbling 9.7% as of 11:28 a.m. ET on Tuesday. The company didn't make any announcements that would...
Novavax Jumps After Pledging To Update Its Covid Shot; Pfizer, Moderna Slip
Investor's Business Daily· 1 year agoNovavax plans to update its Covid shot for new variants, and NVAX stock outperformed its vaccine...
Novavax (NVAX) Stock Increases 9% in a Month: Here's Why
Zacks via Yahoo Finance· 8 months agoThis growth in Novavax (NVAX) is likely due to the rising COVID-19 infection cases in the United...